175 related articles for article (PubMed ID: 28966496)
1. Spectrum of meningioma with special reference to prognostic utility of ER,PR and Ki67 expression.
Mukhopadhyay M; Das C; Kumari M; Sen A; Mukhopadhyay B; Mukhopadhyay B
J Lab Physicians; 2017; 9(4):308-313. PubMed ID: 28966496
[TBL] [Abstract][Full Text] [Related]
2. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
[TBL] [Abstract][Full Text] [Related]
3. Progesterone and estrogen receptors in meningiomas: prognostic considerations.
Hsu DW; Efird JT; Hedley-Whyte ET
J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089
[TBL] [Abstract][Full Text] [Related]
4. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma.
Shayanfar N; Mashayekh M; Mohammadpour M
Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648
[TBL] [Abstract][Full Text] [Related]
5. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
[TBL] [Abstract][Full Text] [Related]
6. Estrogen and progesterone receptor in meningiomas: An immunohistochemical analysis.
Telugu RB; Chowhan AK; Rukmangadha N; Patnayak R; Phaneendra BV; Mowliswara Prasad BC; Reddy MK
J Cancer Res Ther; 2020; 16(6):1482-1487. PubMed ID: 33342817
[TBL] [Abstract][Full Text] [Related]
7. Status of Ki-67, estrogen and progesterone receptors in various subtypes of intracranial meningiomas.
Fakhrjou A; Meshkini A; Shadrvan S
Pak J Biol Sci; 2012 Jun; 15(11):530-5. PubMed ID: 24191627
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in anterior skull base meningiomas.
Ciocan LM; Dănăilă L; Stănculescu DE; Neamţu SD; Mateescu GO; Stanca L
Rom J Morphol Embryol; 2014; 55(3 Suppl):1063-9. PubMed ID: 25607386
[TBL] [Abstract][Full Text] [Related]
9. Histopathological and Immunohistochemical Evaluation of Meningiomas with Reference to Proliferative Markers p53 and Ki-67.
Telugu RB; Chowhan AK; Rukmangadha N; Patnayak R; Phaneendra BV; Prasad BC; Reddy MK
J Clin Diagn Res; 2016 Jan; 10(1):EC15-9. PubMed ID: 26894073
[TBL] [Abstract][Full Text] [Related]
10. WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma.
Maiuri F; Mariniello G; Guadagno E; Barbato M; Corvino S; Del Basso De Caro M
Acta Neurochir (Wien); 2019 Dec; 161(12):2553-2561. PubMed ID: 31637512
[TBL] [Abstract][Full Text] [Related]
11. Epithelial ovarian tumors: Clinicopathological correlation and immunohistochemical study.
Naik PS; Deshmukh S; Khandeparkar SG; Joshi A; Babanagare S; Potdar J; Risbud NS
J Midlife Health; 2015; 6(4):178-83. PubMed ID: 26903759
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical expression of progesterone receptor in relationship with histological grade and risk of relapses in intracranial meningiomas].
Hernández Faraco A; Céspedes G; Trejo E
Neurologia; 2009 May; 24(4):235-44. PubMed ID: 19603293
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of estrogen receptor-related antigen, progesterone and estrogen receptors in human intracranial meningiomas.
Khalid H
Cancer; 1994 Jul; 74(2):679-85. PubMed ID: 8033047
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and individual participant data meta-analysis of gonadal steroid hormone receptors in meningioma.
Miyagishima DF; Sundaresan V; Gutierrez AG; Barak T; Yeung J; Moliterno J; McGuone D; Claus EB; Günel M
J Neurosurg; 2023 Dec; 139(6):1638-1647. PubMed ID: 37243565
[TBL] [Abstract][Full Text] [Related]
15. Hormone receptors in benign intracranial meningiomas.
Milenković S; Berisavac J; Cvetković-Dozić D; Skender-Gazibara M; Bojović V; Berisavac I
J BUON; 2004; 9(3):295-8. PubMed ID: 17415829
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas.
Takei H; Buckleair LW; Powell SZ
Neuropathology; 2008 Feb; 28(1):62-8. PubMed ID: 18021195
[TBL] [Abstract][Full Text] [Related]
17. Meningiomas: correlation of Ki67 with histological grade.
Babu S; Uppin SG; Uppin MS; Panigrahi MK; Saradhi V; Bhattacharjee S; Sahu BP; Purohit AK; Challa S
Neurol India; 2011; 59(2):204-7. PubMed ID: 21483118
[TBL] [Abstract][Full Text] [Related]
18. Is progesteron receptor status really a prognostic factor for intracranial meningiomas?
Iplikcioglu AC; Hatiboglu MA; Ozek E; Ozcan D
Clin Neurol Neurosurg; 2014 Sep; 124():119-22. PubMed ID: 25036873
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
Devaprasath A; Chacko G
Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
[TBL] [Abstract][Full Text] [Related]
20. Proliferation potential of spinal meningiomas.
Roser F; Nakamura M; Bellinzona M; Ritz R; Ostertag H; Tatagiba MS
Eur Spine J; 2006 Feb; 15(2):211-5. PubMed ID: 15926055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
